Jing Zhang
机构:The University of Sydney, Central South University, Capital University, Nanchang University, Hong Kong Polytechnic University, Henry Ford Health System, Sun Yat-sen University, Shanghai Jiao Tong University, Capital Medical University, Anhui Medical University, Nantong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Fudan University, Vancouver Hospital and Health Sciences Centre, China Tobacco, Hong Kong Science and Technology Parks Corporation, Ruijin Hospital, Academy of Military Medical Sciences, Guangxi Normal University, Sichuan Agricultural University, Nanjing University of Posts and Telecommunications, Beijing Tian Tan Hospital, The Seventh Affiliated Hospital of Sun Yat-sen University, Shanghai Ninth People's Hospital, Flex (Mauritius), Shenzhen Bay Laboratory, University of Wisconsin Carbone Cancer Center, Shanghai Public Health Clinical Center, Michigan United, Beijing Institute of Neurosurgery, The First People's Hospital of Changde, National Clinical Research, Stomatology Hospital, First Affiliated Hospital of Anhui Medical University, Wuhan YZY Biopharma (China), Second Xiangya Hospital of Central South University, Hainan Medical College Hospital, Huashan Hospital, Tang Hospital, First Affiliated Hospital Zhejiang University, Southern Medical University, Northwest A&F University, China Medical University, University of South China, Northeast Petroleum University, Shanghai Maritime University
发表论文 455 篇 · 总被引 11187 次 · h-index 53
代表论文
- Role of inflammation in endothelial responses in Pulmonary Hypertension (2025 · Biomedicine & Pharmacotherapy · 被引 8)
- Oral Frailty Assessment Tool: Instrument Development and Cross‐Sectional Validation Study (2025 · Journal of Oral Rehabilitation · 被引 8)
- Peritumoral colonic epithelial cell-derived GDF15 sustains colorectal cancer via regulation of glycolysis and histone lactylation (2025 · Nature Aging · 被引 5)
- Crocin inhibits neutrophil migration and activation to treat hypoxic pulmonary hypertension through targeting HCK (2025 · Phytomedicine · 被引 5)
- Gastrointestinal and Hepatobiliary Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes (2025 · The American Journal of Gastroenterology · 被引 5)
- Genetically engineered Magnesium/Manganese nanoparticles for cancer radioimmunotherapy (2025 · Journal of Nanobiotechnology · 被引 5)